Training Conducted by Core Clinical Research Hospitals (FY2026)

News Highlights

Information regarding training to be conducted by Core Clinical Research Hospitals starting in FY2026 has been released. This training offers important insights for healthcare institution executives, successors, and stakeholders when considering business succession and management strategies. Specifically, it highlights the value for healthcare institutions facing successor issues to consider third-party succession as an alternative to closure or廃業 (business closure), the necessity for early preparation over a 5-10 year span starting around age 60 for chairpersons and directors, and the recommendation to utilize specialized advisors focused on the medical industry.

M&A Medical Editorial Department’s Perspective

The training by Core Clinical Research Hospitals, commencing in FY2026, should be viewed not merely as a promotion of research, but as an initiative that directly addresses the management challenge of healthcare institution sustainability. In particular, given the current situation where many healthcare institutions struggling with lack of successors often fall into the option of “business closure,” the potential for this training to act as a catalyst for third-party succession cannot be ignored. The suggestion that chairpersons and directors should begin succession preparations over a long-term span of 5-10 years from around age 60 aligns perfectly with M&A Medical’s recommendation for “early development of exit strategies.” The necessity of utilizing specialized advisors for the complex management, financial, legal, and human resource issues unique to healthcare institutions reaffirms the significance of entities like ours, specializing in medical M&A brokerage. We hope this training will serve as an opportunity for more healthcare institution executives to concretely consider “business succession = third-party succession” as a viable option.

Points Indicated by This News

• The training by Core Clinical Research Hospitals indirectly suggests the importance of third-party succession for the business continuity of healthcare institutions.
• Early planning of business succession, looking 5-10 years ahead from around age 60, is key to maintaining a sustainable healthcare delivery system.
• Collaboration with industry-specific advisors is essential for resolving issues unique to healthcare institutions.
• A deep understanding of the relationship between training content and business succession is required, and this understanding should be reflected in management strategies.

Practical Questions Arising from This News

• What is the specific content of this training, and how will it be useful for business succession?
• If a successor has not been found by around age 60, what kind of third-party succession schemes can be considered?
• What is the appropriate timing and cost for consulting with a specialized advisor in medical M&A?

If You Feel “Should I Consult Too?”

Is your institution’s chairperson or director around 60 years old and struggling with a lack of successors? It is time to consider “third-party succession” as an option to continue your business while protecting regional medical care, rather than closing down. As this training indicates, preparation looking 5-10 years ahead is essential. First, please consult with specialists focused on medical M&A. We will propose the optimal succession scheme tailored to your institution’s situation and assist in achieving a smooth business succession.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis, as a certified M&A support institution by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here.